Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients

Gastroenterology

Volumn 128, Issue 2, 2005, Pages 313-327

  Sherman, Kenneth E ^a,b   Shire, Norah J ^a,b   Rouster, Susan D ^a   Peters, Marion G ^c   James Koziel, Margaret ^d   Chung, Raymond T ^e   Horn, Paul S ^f,g  

^a Division of Digestive Diseases   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CD4 ANTIGEN; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A;

ADULT; AGE DISTRIBUTION; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL; LYMPHOCYTE COUNT; MALE; MATHEMATICAL MODEL; MICROBIAL KINETICS; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS LOAD; BLOOD; DRUG EFFECT; GENETICS; KINETICS; MIDDLE AGED; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; KINETICS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 14944364658     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.11.059     Document Type: Article

References (29)

1. K.E. Sherman Diagnosis and management of the HCV/HIV-coinfected patient AIDS Clinical Care 14 2002 39 43 48
2. A.S. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela Decay characteristics of HIV-1-infected compartments during combination therapy Nature 387 1997 188 191
3. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107
4. T.J. Layden, N.P. Lam, T.E. Wiley Hepatitis C viral dynamics Clin Liver Dis 3 1999 793 810
5. S. Zeuzem, J.M. Schmidt, J.H. Lee, B. Ruster, W.K. Roth Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo Hepatology 23 1996 366 371
6. K.E. Sherman, S.D. Rouster, P.S. Horn Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus Clin Infect Dis 35 2002 482 487
7. S. Zeuzem, E. Herrmann, J.H. Lee, J. Fricke, A.U. Neumann, M. Modi Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a Gastroenterology 120 2001 1438 1447
8. S. Zeuzem, E. Herrmann First-phase parameters in hepatitis C viral kinetics J Viral Hepat 9 2002 332 333
9. P.J. Rousseeuw, A.M. Leroy Robust regression and outlier detection 1987 Wiley New York
10. F.J. Torriani, R.M. Ribeiro, T.L. Gilbert, U.M. Schrenk, M. Clauson, D.M. Pacheco Early HCV viral dynamics in HIV/HCV-infected patients on HCV Treatment 9th Conference on Retroviruses and Opportunistic Infections 2002 Boston, MA, February 24-28
11. Y. Asahina, N. Izumi, M. Uchihara, O. Noguchi, K. Tsuchiya, K. Hamano A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta Hepatology 34 2001 377 384
12. E. Herrmann, J.H. Lee, G. Marinos, M. Modi, S. Zeuzem Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon Hepatology 37 2003 1351 1358
13. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C a randomised trial Lancet 358 2001 958 965
14. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Jr Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
15. M. Bonacini, S. Govindarajan, L.M. Blatt, P. Schmid, A. Conrad, K.L. Lindsay Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA J Viral Hepat 6 1999 203 208
16. J.M. Matthews-Greer, G.C. Caldito, S.D. Adley, R. Willis, A.C. Mire, R.M. Jamison Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus Clin Diagn Lab Immunol 8 2001 690 694
17. F.J. Torriani, R.M. Ribeiro, T.L. Gilbert, U.M. Schrenk, M. Clauson, D.M. Pacheco Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection J Infect Dis 188 2003 1498 1507
18. D.R. Nelson, C.G. Marousis, T. Ohno, G.L. Davis, J.Y. Lau Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C Hepatology 28 1998 225 230
19. C. Bergmann, J. Layden, R. Levy-Drummer, T. Layden, B. Haagmans, A. Neumann Clinical implications of a new tri-phasic model for hepatitis C viral kinetics during IFN-alpha therapy Hepatology 34 2001 345A
20. J.E. Layden-Almer, R.M. Ribeiro, T. Wiley, A.S. Perelson, T.J. Layden Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin Hepatology 37 2003 1343 1350
21. A.H. Talal, M.T. Shata, M. Markatou, G. Dorante, A. Chadburn, R. Koch Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV J Acquir Immune Defic Syndr 35 2004 103 113
22. G. Lutchman, J.H. Hoofnagle Viral kinetics in hepatitis C Hepatology 37 2003 1257 1259
23. C. Caussin-Schwemling, C. Schmitt, F. Stoll-Keller Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro J Med Virol 65 2001 14 22
24. T. Laskus, M. Radkowski, A. Piasek, M. Nowicki, A. Horban, J. Cianciara Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1 evidence of active replication in monocytes/macrophages and lymphocytes J Infect Dis 181 2000 442 448
25. M. Radkowski, J. Wilkinson, M. Nowicki, D. Adair, H. Vargas, C. Ingui Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system evidence of replication J Virol 76 2002 600 608
26. A.M. Roque Afonso, J. Jiang, F. Penin, C. Tareau, D. Samuel, M.A. Petit Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets J Virol 73 1999 9213 9221
27. N. Goutagny, A. Fatmi, V. De Ledinghen, F. Penin, P. Couzigou, G. Inchauspe Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection J Infect Dis 187 2003 1951 1958
28. F.M. Yan, A.S. Chen, F. Hao, X.P. Zhao, C.H. Gu, L.B. Zhao Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C World J Gastroenterol 6 2000 805 811
29. K.A. Powers, N.M. Dixit, R.M. Ribeiro, P. Golia, A.H. Talal, A.S. Perelson Modeling viral and drug kinetics hepatitis C virus treatment with pegylated interferon alfa-2b Semin Liver Dis 23 Suppl 1 2003 13 18